Electromyographic Analysis of Scapular Muscles During Closed Kinetic Chain Exercises

February 23, 2024 updated by: Elif Turgut, Hacettepe University

Electromyographic Analysis of Scapular Muscles During Closed Kinetic Chain Exercises: The Effect of Glenohumeral Joint Elevation Status on Muscle Activity

In shoulder rehabilitation, the inclusion of kinetic chain exercises is advocated in order to provide the necessary energy transfer to produce optimal force with minimal energy consumption. Closed kinetic chain (CKC) exercises are defined as exercises in which the distal segment is stabilized by encountering significant resistance while the proximal segment moves. In contrast, open kinetic chain (OKC) exercises allow the distal segment to move freely without any resistance. Recently, the importance of closed kinetic chain (CKC) exercises has increased in enhancing shoulder joint neuromuscular control by improving dynamic shoulder stability and joint position sense.

The most current shoulder rehabilitation protocols include exercises for restoration of scapular muscle imbalances.There exist studies investigating the levels of scapular muscle activation during CKC exercises. Researchers have shown that most CKC exercises especially push-ups and plank variations with the shoulder in the 90° position, generally provide high SA activity and an optimal UT/SA ratio.In the literature, there is limited information on how the level of shoulder elevation affects scapular muscle activity and ratio during closed kinetic chain exercises in the prone position. To effectively prescribe CKC exercises commonly used in rehabilitation and athletic programs, a clear understanding of shoulder elevation changes muscle activity during these exercises is required.

Our hypothesis is that glenohumeral joint elevation status will alter scapular muscle activation and activation rates.

Study Overview

Detailed Description

Twenty-two healthy male individuals to recruited in the study. Conducting a power analysis through G∗Power, considering a moderate effect size (f = 0.25), an alpha level of 0.05, and a power of 0.8. The outcome of this analysis indicated a required minimum sample size of 21 individuals. This study was used a randomized, repeated measures cross-over design. Muscle activation levels during maximum voluntary isometric contraction (MVIC) of each muscle (Upper trapezius, Middle trapezius, Lower trapezius, Serratus anterior) will be recorded to normalize muscle activation levels during closed kinetic chain exercises. Muscle activation levels will be evaluated with a surface electromyography device (Noraxon, Myomotion, USA).

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06430
        • Hacettepe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Physically active male individuals (self-reported participating in 150 minutes per week of moderate-vigorous aerobic activity)
  • Being between 18-30 years old
  • Having full range of motion of shoulder without pain
  • Having a body mass index less than 30 kg\m2.

Exclusion Criteria:

  • Having pain in any kinetic chain of the body, had history of any musculoskeletal problems or orthopaedic surgery,
  • Having symptoms in at least one of the screening tests (Hawkins-Kennedy, Neer, Resistant External Rotation, Jobe and Apprehension Test),
  • Being diagnosed with a rheumatic, systemic or neurological disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Superficial electromyography
Electrode placement was performed on the participants' dominant side UT, MT, LT, and SA muscles. Following this, superficial electromyography measurements were performed during maximal voluntary isometric contraction tests and six different upper extremity closed kinetic chain exercises.
For all MVICs, five seconds of each repetition were included in the analysis and the maximum value of three repetitions was taken. For all exercises, the middle 3 seconds of the 5 second data collection period were included in the analysis and the average muscle activation level of the three repetitions was recorded. The average signal amplitude of each exercise was divided by the MVIC of each muscle of interest to obtain the %MVIC value.
Other Names:
  • sEMG

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle activation recorded with surface electromyography (sEMG) during CKC
Time Frame: 2 hours for each participant
In this study, muscle activations of the Upper Trapezius (UT), Middle Trapezius (MT), Lower Trapezius (LT), and Serratus Anterior (SA) muscles during six different closed kinetic chain (CKC) exercises will be investigated. The exercises include Low Plank Plus, High Plank Plus, Stir the Pot, Body Saw, Dolphin Press, and Pike Press. The average signal amplitude of each exercise will be divided by the Maximum Voluntary Isometric Contraction (MVIC) of each muscle of interest to obtain the %MVIC value. The average %MVICs will also be used for UT/MT, UT/LT, and UT/SA ratio calculations.
2 hours for each participant

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 25, 2022

Primary Completion (Actual)

April 30, 2023

Study Completion (Actual)

June 20, 2023

Study Registration Dates

First Submitted

February 1, 2024

First Submitted That Met QC Criteria

February 15, 2024

First Posted (Actual)

February 23, 2024

Study Record Updates

Last Update Posted (Estimated)

February 26, 2024

Last Update Submitted That Met QC Criteria

February 23, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is not a plan to make IPD available.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Injuries

Clinical Trials on Superficial Electromyography

Subscribe